Degroof Petercam Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.48M Hold
18,655
0.03% 297
2023
Q4
$2.57M Buy
+18,655
New +$2.45M 0.03% 299

Other funds holding DGX

Degroof Petercam Asset Management's DGX Position: Q1 2024 in Review

Degroof Petercam Asset Management held its Quest Diagnostics (DGX) position steady in Q1 2024 at 18,655 shares worth $2.48M. The position accounts for 0.03% of the portfolio, ranked #297.

Degroof Petercam Asset Management first reported a position in DGX in Q4 2023 and has held it in 2 quarters since. The position peaked at $2.57M in Q4 2023. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Degroof Petercam Asset Management held 18,655 shares of Quest Diagnostics worth $2.48M as of Q1 2024.
  • Degroof Petercam Asset Management left its Quest Diagnostics share count unchanged in Q1 2024.
  • Quest Diagnostics made up 0.03% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #297 holding.
  • Degroof Petercam Asset Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 2 quarters since.
  • Degroof Petercam Asset Management's Quest Diagnostics position peaked at $2.57M in Q4 2023.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.